• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述羟氯喹的不良皮肤作用:一项系统综述。

Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.

机构信息

Department of Dermatology, University of California, Irvine, California.

Department of Dermatology, University of California, San Diego, La Jolla, California.

出版信息

J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.

DOI:10.1016/j.jaad.2020.04.024
PMID:32289395
Abstract

BACKGROUND

Hydroxychloroquine is associated with myriad adverse dermatologic effects, most of which are poorly characterized by the literature, with unknown frequencies and risk factors.

OBJECTIVE

To conduct a systematic review of the adverse dermatologic effects and predisposing factors of hydroxychloroquine toxicity.

RESULTS

The review included 94 articles comprising 689 dermatologic adverse effects. A total of 21 unique dermatologic reactions were reported, most commonly drug eruption or rash (358 cases), cutaneous hyperpigmentation (116), pruritus (62), acute generalized exanthematous pustulosis (27), Stevens-Johnson syndrome or toxic epidermal necrolysis (26), hair loss (12), and stomatitis (11). Almost all underlying conditions were rheumatologic or autoimmune in nature, composed primarily of lupus erythematous (72% of all cases) and rheumatoid arthritis (14%). The range of reported mean cumulative dosages was wide, with some adverse reactions found after as little as 3 g or as much as 2500 g.

LIMITATIONS

Dermatologic adverse events and primary diagnoses related to the use of hydroxychloroquine may be under-reported as only case reports and clinical trials that reported at least 1 dermatologic adverse effect were included.

CONCLUSION

Although hydroxychloroquine is generally well tolerated, dermatologic adverse effects involving the skin, hair, or nails are a frequent and significant complication. Most of these reactions occurred after treatment of autoimmune conditions, often manifesting on the skin after a wide range of cumulative dosages.

摘要

背景

羟氯喹与众多不良皮肤效应相关,其中大多数在文献中描述得并不完善,其频率和风险因素未知。

目的

对羟氯喹毒性的不良皮肤效应和易患因素进行系统回顾。

结果

该综述纳入了 94 篇文章,共包含 689 例皮肤不良事件。共报告了 21 种独特的皮肤反应,最常见的是药物疹或皮疹(358 例)、皮肤色素沉着(116 例)、瘙痒(62 例)、急性泛发性发疹性脓疱病(27 例)、史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症(26 例)、脱发(12 例)和口腔炎(11 例)。几乎所有的潜在疾病本质上都是风湿性或自身免疫性的,主要由红斑狼疮(所有病例的 72%)和类风湿性关节炎(14%)组成。报告的平均累积剂量范围很广,有些不良反应在累积剂量仅 3g 或多达 2500g 时就出现了。

局限性

与羟氯喹使用相关的皮肤不良事件和主要诊断可能报告不足,因为仅纳入了报告至少 1 种皮肤不良事件的病例报告和临床试验。

结论

尽管羟氯喹通常具有良好的耐受性,但皮肤、毛发或指甲的皮肤不良效应是一种常见且严重的并发症。这些反应大多发生在治疗自身免疫性疾病之后,经常在累积剂量广泛的情况下在皮肤上表现出来。

相似文献

1
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.描述羟氯喹的不良皮肤作用:一项系统综述。
J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.
2
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.羟氯喹引发急性泛发性脓疱性皮病与史蒂文斯-约翰逊综合征重叠:一例报告
J Med Case Rep. 2020 Nov 3;14(1):210. doi: 10.1186/s13256-020-02504-8.
3
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events.羟氯喹的安全性概况:主要皮肤和皮肤外不良事件。
Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1099-1107. doi: 10.55563/clinexprheumatol/styx9u. Epub 2021 Feb 15.
4
Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.靶向治疗和免疫治疗的皮肤、口腔黏膜、头发和指甲毒性副作用。
Am J Clin Dermatol. 2018 Nov;19(Suppl 1):31-39. doi: 10.1007/s40257-018-0384-3.
5
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.羟氯喹诱发的急性泛发性发疹性脓疱病:加拿大首例病例报告及文献复习。
J Cutan Med Surg. 2013 Nov-Dec;17(6):414-8. doi: 10.2310/7750.2013.12105.
6
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.羟氯喹诱导的急性泛发性脓疱性皮病:1例非典型临床表现病例
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
7
Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.系统性疾病中羟氯喹诱导的色素沉着:患病率、临床特征及危险因素:一项41例的横断面研究
Lupus. 2017 Oct;26(12):1304-1308. doi: 10.1177/0961203317700486. Epub 2017 Mar 29.
8
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.免疫检查点抑制剂的皮肤不良反应:皮肤毒性与免疫治疗
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.
9
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature.羟氯喹诱导的急性泛发性脓疱性皮病:三例报告并文献复习
Clin Ther. 2008 May;30(5):930-40. doi: 10.1016/j.clinthera.2008.05.014.
10
[Drugs associated with acute generalized exanthematic pustulosis].[与急性泛发性脓疱性皮病相关的药物]
Ann Dermatol Venereol. 2003 Jun-Jul;130(6-7):612-8.

引用本文的文献

1
Cutaneous Adverse Effects of Hydroxychloroquine and Leflunomide in Connective Tissue Diseases: A Report of Three Cases and a Literature Review.羟氯喹和来氟米特在结缔组织病中的皮肤不良反应:三例报告及文献综述
Cureus. 2025 Jun 7;17(6):e85495. doi: 10.7759/cureus.85495. eCollection 2025 Jun.
2
A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic.一项针对先前报道的天疱疮药物触发因素的全面、基于人群水平的评估突出了免疫调节能力这一共同特征。
Front Immunol. 2025 Jan 21;15:1508129. doi: 10.3389/fimmu.2024.1508129. eCollection 2024.
3
Safety of Hydroxychloroquine: What a Dermatologist Should Know.
羟氯喹的安全性:皮肤科医生应了解的内容。
Am J Clin Dermatol. 2025 Mar;26(2):251-264. doi: 10.1007/s40257-025-00919-x. Epub 2025 Feb 3.
4
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System.评估羟氯喹使用量的新冠相关激增与天疱疮报告增加之间的关联:对美国食品药品监督管理局不良事件报告系统的不成比例性分析
Front Immunol. 2024 Dec 20;15:1470660. doi: 10.3389/fimmu.2024.1470660. eCollection 2024.
5
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with HLA-typing.羟氯喹诱导的急性泛发性脓疱性皮病伴HLA分型
Pharmacogenomics. 2024;25(14-15):569-572. doi: 10.1080/14622416.2024.2430167. Epub 2024 Nov 18.
6
Drug-Induced Pigmentation: A Review.药物诱导性色素沉着:综述。
Drugs. 2024 Sep;84(9):1071-1091. doi: 10.1007/s40265-024-02062-z. Epub 2024 Aug 1.
7
Hydroxychloroquine-induced pigmentation in rheumatic diseases: prevalence, clinical features and influencing factors.羟氯喹引起的风湿性疾病色素沉着:患病率、临床特征及影响因素
Rheumatology (Oxford). 2025 Mar 1;64(3):985-993. doi: 10.1093/rheumatology/keae217.
8
Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography angiography.使用光学相干断层扫描血管造影术评估长期服用羟氯喹患者的早期视网膜变化。
Ther Adv Drug Saf. 2024 Jan 27;15:20420986231225851. doi: 10.1177/20420986231225851. eCollection 2024.
9
Adverse cutaneous reaction to hydroxychloroquine in a patient with anti-SAE-1-positive dermatomyositis and a history of diffuse large B-cell lymphoma.一名抗SAE-1阳性皮肌炎且有弥漫性大B细胞淋巴瘤病史的患者对羟氯喹产生的皮肤不良反应。
Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):158-161. doi: 10.1080/08998280.2023.2274231. eCollection 2024.
10
Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate.与甲氨蝶呤相比,皮肌炎患者使用羟氯喹治疗出现皮肤不良反应的几率更高。
ACR Open Rheumatol. 2023 Nov;5(11):594-599. doi: 10.1002/acr2.11605. Epub 2023 Sep 24.